HILLSTREAM BIOPHARMA INC (HILS)
US4327051011 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to HILS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.08. This target is 1670.07% above the current price.
HILS was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about HILS.
In the previous month the buy percentage consensus was at a similar level.
HILS was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-07-17 | Dawson James | Downgrade | Buy -> Neutral |